Investor Relations
Press Releases
November 29, 2022
Allakos Announces Publication of AK006 Mechanism of Action Manuscript in Communications Biology
November 10, 2022
Allakos Presents Preclinical Data on AK007, a Siglec-10 Antagonist Antibody, at the Society for Immunotherapy of Cancer’s 37th Annual Meeting
November 7, 2022
Allakos Provides Business Update and Reports Third Quarter 2022 Financial Results